Improving survival for patients with prostate cancer diagnosed in the prostate-specific antigen era

Urology

Volumn 48, Issue 1, 1996, Pages 67-71

  Gilliland, Frank D ^a,b   Hunt, William C ^a   Key, Charles R ^a  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NEW MEXICO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ANTIGEN DETECTION; ARTICLE; CANCER SCREENING; CANCER SURVIVAL; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; SURVIVAL TIME;

EID: 0030200862     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(96)00083-0     Document Type: Article

References (32)

1. Boring CC, Squires TS, Tong T, Montgomery S. Cancer statistics. CA. 44:1994;7-26.
2. Greenwald P. Prostate cancer. Schottenfeld D, Fraumeni JF. Cancer Epidemiology and Prevention. 1982;938-946 WB Saunders, Philadelphia.
3. Mandel JS, Schuman LM. Epidemiology of prostate cancer. Lilienfeld AM. Reviews in Cancer Epidemiology. 1:1980;1-83 Elsevier, New York.
4. Nomura AM, Kolonel LN. Prostate cancer: a current perspective. Epidemiol Rev. 13:1991;200-227.
5. Mettlin C, Jones GW, Murphy GP. Trends in prostate cancer care in the United States, 1974-1990: observations from the patient care evaluation studies of the American College of Surgeons Commission on Cancer. CA. 43:1993;83-91.
6. Mettlin C, Jones G, Averette H, Gusberg SB, Murphy GP. Defining and updating the American Cancer Society Guidelines for the cancer-related checkup: prostate and endometrial cancers. CA. 43:1993;42-46.
7. Walsh PC. Why make an early diagnosis of prostate cancer. J Urol. 147:1992;853-854.
8. Catalona WJ, Smith DS, Ratliff TL, Basler JW. Detection of organ-confined prostate cancer is increased through prostate-specific antigen-based screening. JAMA. 270:1993;948-954.
9. Chodak G. Prostate cancer: to screen or not to screen. Acta Oncol. 30:1991;285-287.
10. Ries LAG, Miller BA, Hankey BF, Kosary CL, Harras A, Edwards BK. SEER cancer statistics review: 1973-1991: tables and graphs. 1994;National Cancer Institute, Bethesda, MD. (NIH Pub. No. 94-2789).
11. Potosky AL, Miller BA, Albertsen PC, Kramer BS. The role of increasing detection in the rising incidence of prostate cancer. JAMA. 273:1995;548-552.
12. Sakr WA, Cassin BF, Pontes JE, Crissman JD. The frequency of carcinoma and intraepithelial neoplasia of the prostate in young male patients. J Urol. 150:1993;379-385.
13. Johansson JE, Adami HO, Andersson SO, Bergstrom R, Krusemo UB, Kraaz W. Natural history of localised prostatic cancer: a population-based study in 223 untreated patients. Lancet. 1:1989;799-803.
14. Fleming C, Wasson JH, Albertsen PC, Barry MJ, Wennberg JE. A decision analysis of the alternative treatment strategies for clinically localized prostate cancer. JAMA. 269:1993;2650-2658.
15. Lu-Yao GL, McLerran D, Wasson J, Wennberg JE. An assessment of radical prostatectomy: time trends, geographic variation, and outcomes. JAMA. 269:1993;2633-2636.
16. Morrison A. 2nd ed. Screening for Chronic Disease. 1992;Oxford University Press, New York.
17. Gilliland F, Becker TM, Smith A, Key CR, Samet JM. Trends in prostate cancer incidence and mortality in New Mexico are consistent with an increase in effective screening. Cancer Epidemiol Biomarkers Prev. 3:1994;105-111.
18. Key CR. Cancer incidence and mortality in New Mexico, 1973-77. Young JL, Percy CL, Asire AJ. Surveillance, Epidemiology and End Results (SEER): Incidence and Mortality Data, 1973-1977. 1981;489-595 US Government Printing Office, Washington, DC.
19. Wiggins CL, Samet J. Methods. Becker TM, Wiggins CL, Elliott RS, Key CR, Samet JM. Racial and Ethnic Patterns of Mortality in New Mexico. 1993;University of New Mexico Press, Albuquerque, NM.
20. Wiggins CL, Becker TM, Key CR, Samet JM. Stomach cancer among New Mexico's American Indians, Hispanic whites, and non-Hispanic whites. Cancer Res. 49:1989;1595-1599.
21. Shambaugh EM, Gloeckler Ries L, Young JL, Kruse MA. SEER Extent of Disease: 1988 Codes and Coding Instructions. 1992;National Institutes of Health, National Cancer Institute, Rockville, MD.
22. Cunningham J, Hankey B, Lyles B, et al. revised edition The SEER Program Code Manual. 1992;National Cancer Institute, Bethesda, MD. June 1992.
23. Shambaugh EM, Weiss MA, Ries L, et al. Comparative Staging Guide for Cancer. 1993;US Department of Health and Human Services, Bethesda, MD.
24. Percy C, Van Holten V, Muir C. 2nd ed. International Classification of Diseases for Oncology. 1990;World Health Organization, Geneva.
25. Cox D. Regression models and life tables. J R Stat Soc (B). 34:1972;187-220.
26. SAS User's Guide: Statistics. 1990;SAS Institute, Inc, Cary, NC. version 6.
27. Gilliland FD, Becker TM, Key CR, Samet JM. Contrasting trends of prostate cancer incidence and mortality in New Mexico's Hispanics, non-Hispanic whites, American Indians, and Blacks. Cancer. 73:1994;2192-2199.
28. Gray GF Jr, Marshall VF. Squamous carcinoma of the prostate. J Urol. 113:1975;736-738.
29. Mettlin CJ, Murphy G. The National Cancer Data Base report on prostate cancer. Cancer. 74:1994;1640-1648.
30. Schmidt JD, Mettlin CJ, Natarajan N, Peace BB, Beart RW Jr, Winchester DP, Murphy GP. Trends in patterns of care for prostatic cancer, 1974-1983: results of survey by the American College of Surgeons. J Urol. 136:1986;416-421.
31. Perez CA, Garcia D, Simpson JR, Zivnuska F, Lockett MA. Factors influencing outcome of definitive radiotherapy for localized carcinoma of the prostate. Radiother Oncol. 16:1989;1-21.
32. Walsh P. Radical prostatectomy with reduced morbidity: an anatomic approach. NCI Monogr 1988. 7:1988;133-137.